Clinical/preclinical Consortium

APTrans

APTrans is a consortium of three drug development companies, all based at Alderley Park, who offer a wide spectrum of skills and experience needed for the smooth running of drug development programmes. The proximity of the three companies facilitates a quick response to any issues should they arise.

In addition to Aptus Clinical, which specialises in the clinical aspects of drug development, APTrans includes:

ApconiX

• Team of world-renowned nonclinical safety experts
• Ion channel screening
• Target safety assessments
• Drug project toxicology

SEDA Pharmaceutical Development Services

• Integrated pharmaceutical development and clinical pharmacology service
• Chemistry manufacturing and controls
• Formulation strategy
• Drug delivery system scouting
• Clinical pharmacology and biopharmaceutics